NASF PRE-CONFERENCE • March 6 • 2012
Newsletter from Marelife • November • 2012
todeliverVisionPaper | BlueBioFinal| DNAVaccinationofFish|
"BioVerdi" is hosted at Oslo Science Center. This picture is taken when Minister of Trade and Industry, Trond Giske (center), inaugurated the new StartupLab,
September 2012. Karl Christian Agerup, CEO Forskningsparken (left) and Ole Petter Ottersen, rektor, University of Oslo (right).
Photo: Gorm K. Gaare.
THE MARELIFE NEWS • NOVEMBER • 20122
Norwegian bioeconomy is behind the pioneering «BioVerdi»
project, based at Oslo Innovation Center. 23 top executives
have signed the partnership declaration.
The project picks up the results from recent large report made by
Oslo Business School, «Et kunnskapsbasert Norge» (A knowledge
based Norway), wich reflects the status of the most important
Norwegian industry sectors. "Bio Verdi" aims at adressing the
challenges and opportunities of the bio sector part of these
industries, and to provide recommandations to enhance
innovation. The project has been well received in all environ-
ments, from universities and industry to venture capital sector.
The analytical approach is robust: experts from all bio economy
sectors; medicine, marine, agro and industry together with Academia
and capital owners have formed working groups, the main delivery
from which is to propose on important measures to be implemented
for the purpose to foster enhanced innovation in the Norwegian
bioeconomy sectors. The recommendation short list will be substanti-
ated by mobilizing adequate analyses, statistics to support the pro-
“BioVerdi” is a cross field and trans boundary initiative to develop
a stronger "ecosystem" of innovation. The project is established in
partnership between leading R&D units, industry representatives
from bio production and pharma, capital owners and with support
from public policy system and authorities.
The partners commitment and ownership to the project are
based on a planning document written by Øystein Lie. “Bio Verdi”
seeks to establish an International Advisory Board, represented by
the Nordics, UK, USA and Singapore. “BioVerdi” intends to try to con-
nect to “The Norwegian Industrial Biotechnology Network”, as a pos-
sible pilot or demonstration project.
In essence the Norwegian bioeconomy sector is behind the pro-
ject since top excecutives of the leading players of all four major
branches: Marine, agri, health and process industry together with
R&D organisations have endorsed its ideas and goals.
These executives has signed the document: Ole Petter Ottersen
(Rektor UiO), Hans Fredrik Hoen (Rektor UMB), Yngvild Wasteson
(Rektor NVH), Øyvind Fylling Jensen (Adm. dir. Nofima), Greta
Bentzen (NIVA), Gudmund Holstad (Adm. dir. Veterinærinstituttet),
Ole Kristian Hjelstuen (Adm. dir. Inven2), Tom Colbjørnsen (Rektor
BI), Frank Larsen (Adm. dir. Hedmark Kunnskapspark), Mariann
Ødegaard (Adm. dir. Kjeller Innovasjon), Karl Christian Agerup
(Adm. dir. Forskningsparken), Hilde Steineger (Vice president Pro-
nova Biopharma), Odd Magne Rødseth (Adm. dir. AquaGen), Jon
Hindar (Adm. dir. Cermaq), Idun Christie (Adm. dir. Graminor), Runar
Larsen (Adm. Dir. Nortura), Sverre Bjørnstad (Adm. dir. Geno), Ove
Lerdahl (Adm. dir. Agroplas), Knut Thomas Traaseth (Gener-
alsekretær Norsk Venturekapitalforening), Arne Handeland (Part-
ner Verdane Capital), Sigbjørn Gregusson (BioBank AS), Carl Seip
Hanevold (Styreleder MareLife), Gudbrand Rødsrud (CTO Bor-
In fact, the spirit and cross sector engagements behind the Nor-
wegian aquaculture industrial revolution is again reflected in
THE MARELIFE NEWS • NOVEMBER • 2012 3
BioVerdi. This is one major motif why MareLife chair, Carl Seip Hane-
vold and many of MareLife members involve in BioVerdi. They fore-
see new synergistic powers to be tapped for the blue sector through
A think tank aiming at producing a vision paper with work-
ing title: “Solutions needed to expand global aquaculture
substantially to meet with future food demands” is to be in
action in advance of and ready to present short list action
points at the NASF Day Zero in Bergen. This is one of many
new features at the popular innovation seminar warming up
the North Atlantic Seafood Forum.
When the very first NASF makes its takeoff in the “world mar-
ine?(seafood) capital” Bergen on Tuesday March 5h, the focus will
be on global aquaculture solutions (GAS), how to innovate new
solutions to advance the aquaculture sector.
Day Zero will be chaired by Karl Almås, CEO SINTEF Fishery &
Aquaculture, and moderated by Jostein Refsnes (Chair Norlaks). The
seminar is hosted by MareLife, manager Øystein Lie, and Fiskerifor-
um Vest, manager Tanja Hoel. The main NASF Day Zero Partner is
The Norwegian Seafood Research Fund.
Minister of Fisheries and Coastal Affairs, Lisbeth Berg-Hansen
will be invited to give the opening address, and opening keynote
speech will be delivered by George Chamberlain, president of Global
Themes to be focused are the feed capacity and a series of other
important issues and the search for corresponding solutions to se-
cure a sustainable expansion of the global aquaculture business.
According to Øystein Lie and Tanja Hoel the seminar is designed
in these days, and it will consist of chapters on aquaculture in tem-
perate, tropical and cold water. Solutions in critical fields like the be-
low listed will be highlighted:
o Complete genome based breeding regimes
o Novel vaccination strategies for sustainable fish farming
o Revealing new insight to fight viral, bacterial and parasite in-
o New feed resources and technologies (algae etc)
o Gear and engineering solutions
o Sustainable catch of wild resources and maximized utilization
of corresponding byproducts for aquafeeds and ingredients
o Solutions for space and water
o Necessary legislations, standards of quality and best practices
More about NASF 2013:
The interreg project BlueBio, where MareLife has been an
active partner, was concluded at a conference at Marstrand
Havshotell, Thursday November 29.
Blue Bio has brought about active networking between academy,
industry and society, to promote sustainable marine innovations.
“Blue Biotech for sustainable innovations” (Blue Bio) is a cross-
border project in the Kattegatt-Skagerack region, and it has been
working towards knowledge-based development and integration of
research and industry. The goal is to find sustainable ways of ex-
ploiting the marine environment and resources.
Blue Bio has been working towards expanding the potential for
the industrial use of microalgae. With relevant research, industrial
collaborations and development of the marine innovation platform,
Blue Bio reinforces microalgae as a valuable resource for industries
working with foodstuffs, feeds, nutrition, pharma and bioenergy.
A new area of competence
At the end 2012 the project group of Blue Bio will hand over sug-
gestions and tools for further development of marine biotechno-
logy in the KASK-region to the intrinsic innovation system. This
includes a handbook of innovation in the marine environment, an
analysis of the current state and future potential for industrial
use of microalgae, and a marine biotechnology platform of relev-
ant researchers, companies and new innovation cases, which have
been knitted together through several workshops and confer-
Project members in Sweden and Norway: University of Gothen-
burg (Lead Partner), Innovationskontor Väst, Chalmers University of
Technology, MareLife (Norwegian project owner), Norwegian Uni-
versity of Life Sciences (UMB), Kjeller Innovasjon
Concrete core deliverables from the project are: Microalgae mar-
ket and technology analysis, Development of manual for commercial-
ization/startups for the universities, Assisting in commercialization
of a series of R&D cases, Running relevant marine biotech work-
Tanya Hoel, CEO, Fiskeriforum Vest.
THE MARELIFE NEWS • NOVEMBER • 20124
THE MARELIFE NEWS - NEWSLETTER TO MARELIFE MEMBERS
EDITOR-IN-CHIEF: Øystein Lie | email@example.com
PRODUCED BY: Oslo Business Memo | firstname.lastname@example.org
infocus- Dec. 11-2012
What is the impact of DNA vaccines on fish farming, and
how should it be regulated in the future? This topics will be
focused at at seminar orgainzed by Bioteknolo-
ginemnda/The Norwegian Biotechnology Advisory Board,
Representatives from research institutions and government will
participate at the lunch seminar Tuesday, December 11, at Rica Vic-
toria Hotel in central Oslo.
Professor Espen Rimstad, National Veterinary Institute, research-
er Paul Midtlyng, Novartis, researcher Helena Hauge, National Veter-
inary Institute and senior advisor Casper Linnestad, Department of
Environment. They will give key-note speaches, followed by debate
coached by Director general Sissel Rogne, Bioteknologinemnda.
Main topics are the developing of DNA vaccines and the impact
on fish farming industry, and how it should be regulated by the au-
thorities. Check out more about the seminar and register your parti-
“AlgInnova”: a series of workshops, market analyses and projects
together with the Storby Marin network, the BlueBio consortium, UNI
Research Bergen, Innovation Norway and commercial members of
“Green Fishing Vessel”: a multi component project aiming at de-
veloping a fishing vessel with lowest possible carbon foot print and
at the same time equipped with sensors to monitor ocean environ-
ments. Liegruppen, Rolls Royce, Telenor, Det norske veritas, NIVA,
SINTEF Fishery and aquaculture, Institute of marine research
“GenTrack”: reports, verifications and R&D projects aiming at de-
veloping a system for full fledge DNA tracing of nation wide salmon
biomass. AquaGen, GenoMar, Akva Group, BioBank, UMB/Cigene,
Norwegian School of Veterenary Science, Nofima, Norw. Seafood Re-
search Fund, The Norwegian Seafood Federation and its new envir-
“AquaGenome”: complete genome sequence assisted R&D ap-
proaches to optimize breeding operations and enhance insight into
marine resource structures and dynamics. University of Oslo (CEES)
together with national and international academic alliances and lead-
ing aqua genetics and breeding companies like AquaGen.
“NOR-Openscreen”: the Norwegian EU-OpenScreen Node at the
Biotechnology Center, University of Oslo, employing chemical space
and bio assays (chemBio) for high throughput drug discovery. Also
linked with marine bioprospecting efforts in Tromsø, Trondheim and
“AquaFarmControl”: an intelligent capsule based system under
development to prevent escapees from the farm. Seafood Security
AS together with Norwegian and EU allies.
“Protective immune responses in Atlantic salmon”: an immunome
(translated immune genes) based R&D approach to provide new
knowledge base on immune gene functions as a mean for improved
vaccine development and other disease control measures in salmon.
University of Oslo, Norwegian School of veterinary medicine togeth-
er with commercial players in the vaccine and aquaculture sector.
The MareLife miniseminar concept was again a great suc-
cess, Sept. 19-2012. This time featuring one of the out-
most important issues for the sector reputation:
Environmental issues with emphasis on tracing and prevent-
ing escapees in aquaculture.
This is likely the reason for the success of this seminar concept:
always sector important issues on the agenda and it attracts a di-
verse array of players again which foster vibrant cross talk.
Around 40 people covering producers, technical solution pro-
viders, R&D entities, sector umbrella organizations, fishery authorit-
ies, NGOs and press gathered at Oslo Innovation center.
The presentations were chaired by Øystein Lie and the sub-
sequent discussion by Jostein Refsnes.
The agenda was set and presentations were opened by the Nor-
wegian Seafood Federation (FHL) director on environmental issues:
Aina Valland with an overview of their new enforced emphasis on
environmental issues: sealice, fish health, escapees, feed resources,
installment of a new fund etc.
This main talk was followed by a series of technical solutions for
tracing (DNA based tracing by Sisse Kjøglum AquaGen and Matthew
Baranski Nofima, , physical tagging by Pål Chr Kruger Europharma
and preventing escapees by Håvard Haraldsen Havtek and Carl Ivar
Holmen, Seafood Security.
A vibrant discussion took place chaired by Jostein Refsnes.
Although there was quite a distance in the position of the NGOs
present and the aquaculture sector people as of the reality picture of
the threats and impact of cultured on wild salmon, there was a con-
sensus that more knowledge was needed. The ongoing DNA projects
would assist on advancing our knowledge about these interactions
Blue Bio Project Manager Camilla Petterson (left), University
of Gothenburg, and Prof. Øystein Lie, Executive Manager,
MareLife. Photo: Erik Lopez Fedde
THE MARELIFE NEWS • NOVEMBER • 2012 5
and thus also advance our dialogue in addition to the cost efficient
tracing power of these.
Also it was emphasized the need of instantly knowing wild or es-
caped and from where, at the moment too challenging to the DNA-
method but also here there is a continuous development in speed of
analysis. It was also suggested that the one method did not exclude
the other but rather could mutually strengthen. Hence, also a physic-
al tagging method was presented by Europharma.
Overall there was also a consensus that the ultimate goal is to
prevent most and ideally all escapees and this vision was addressed
by two concepts: the intelligent electronic net by Havtek and the re-
sponder tag by Seafood Security.
The presentations can be retrieved from the download section
together with program and participant list.
The future of Norwegian and International aquaculture are
focused at a symposium in The Norwegian Academy of Sci-
ence and Letters, Wednesday, January 30.
Minister of Fisheries and Coastal Affairs, Lisbeth Berg-Hansen, is
the first in the row of top key-note speakers at the symposium
with topics ranging from the general picture and overview to
technological challenges and innovation. Director Christina
Abildgaard, Director Karl A. Almås, Professor Roy H. Gabrielsen,
Professor John Grue and Director Fridtjof Unander is in the advis-
ory board preparing the symposium.
Key-notes will be held by Karl A. Almås, SINTEF, Lasse Taranger,
Havforskningsinstituttet, Yngvar Olsen, NTNU, Ragnar Tveterås, Uni-
versity of Stavanger and Liv Monica Subholt, Kvaerner ASA. More in-
formation closer to January 30, on the web:
The Government launched recently its major long term marine
R&D and innovation strategy for Norway: HAV21. Research Coun-
cil of Norway acted as sectretariat for the report. MareLife and al-
lies, especially through the Storby Marin-network has been a
bottom up driving force to realize this report not least through its
Havlandet Norge report 2010. Read the report here:
SINTEF together with DKNVS and NTVA recently presented a hol-
istic analysis of the marine capacity of Norway in a global con-
text. Read the SINTEF report here:
Both above reports together with EU and international reports
from FAO etc will act as very useful back drops for MareLife and allies
innovation session NASF Day Zero, Bergen March 5, where Global
Aquaculture solutions will be put on the agenda as a main topic.
MareLife is in the process of formalizing strategic collaborat-
ive constructions with Biomarine Business Convention,
Global Aquaculture Alliance (GAA) and Iceland Ocean Cluster.
Recently the North Atlantic Ocean Cluster Alliance was founded
with representatives from Norway, Iceland, Greenland, the Faroe
Islands, Denmark and Newsfoundland Canada. This cooperation is
sponsored by NORA and Nordic Innovation and will be lead by Ice-
land. One focus area where MareLife will be involved is to work
together to enhance to competence for better utilization of
byproducts form wild catch.
MareLife fosters innovation through facilitating cross talk
between the private sector, the public sector and the R&D entit-
ies forming a triple helix. Our organisation is receiving critical im-
portant grants from The Research Council of Norway, Oslo
Municipality and Akershus County Council through the VRI pro-
gram to supoort this way of advancing innovation in the marine
Our strategic collaboration with Innovation Norway both nation-
ally, through the biotech industrial network, and abroad is an import-
ant part of the MareLife activities. Noteably The Norwegian
Industrial Biotechnology Network, with several MareLife members
Magazine No 2,
printed in London
THE MARELIFE NEWS • NOVEMBER • 20126
PAVING THE WAY
In several projects the Salmon, Trout and Cod Genome
research has brought new, significant steps forward, and
will in the coming years form the basis for development and
commercialization of new products and services in the
aquaculture sector according to the Aqua Gene
- Aqua Gens early investments in the dual platforms of
biotechnology and breeding has already led to new products that
give the aquaculture sector more choices for improving
productivity and sustainability. The completion of the salmon
genome, combined with the Biotech 2021 program in Norway and
Blue Genomics consortiumin Chile will build a solid fundament for
new innovative products and services that will reach the
marketplace in near future, says Odd Magne Rødseth, CEO, Aqua
Head of research at AquaGen, Nina Santi, says the company now
exploits the knowledge from the Salmon Genome Project to improve
the farmed salmons survival and quality.
- Through focused product development, ourt products with
increased IPN and PD resistance are already in the market, and with
markers for fillet colour coming to market soon, says Santi.
She reveals other tools to be used in further research: Three new
SNP chips developed by Aqua Gen in collaboration with CIGENE/UMB,
two for salmon and one for trout. The first salmon chip will contain
some 950 000 SNP, which is a giant leap forward compared to what
is available today. The best chip at the moment contain some 6 000
SNP. These chips represents total new powerful tools for identifying
industrial important genes, the information of which will advance
salmonid genetic enhancements to new levels.
According to Nina Santi, AquaGen puts great effort in
collaboration with researchers both in Norway and internationally,
and to enhance the knowledge regarding the salmon genome and
methods of selection.
In the RCN BIOTEK2021 program, AquaGen - together with three
partners - will contribute through the recently granted AQUAGENOME
project under the supervision of CEES, University of Oslo.
- We will bring the work with the salmon and cod genomes into
the next phase, Santi says.
In the project 1000 genomes of each species shall be sequenced,
mapping the geneti variation within the species. The genetic
variation is the main basis for any breeding progress.
New methods to develop sterile salmon, SALMOSTERILE
managed by HI, is another research project with which AquaGene is
Odd Magne Rødseth, CEO, Aqua Gen: A solid fundament for new innovative products and services that will reach the
marketplace in near future. Photo: Gorm K. Gaare.
Research in Salmon
Genome has led to
Photo: Aqua Gen
THE MARELIFE NEWS • NOVEMBER • 2012 7
involved in collaboration with three industrial partners. This
research can help to solve the problems concerning potential adverse
genetic interaction between escaped farmed salmon and wild
Finally Nina Santi says the new Chilean consortium Blue
Genomics Chile, will be an important platform to address issues as
SRS and Caligus.
The consortium consisting of Aqua Gen ASA, Aqua Gen Chile SA,
Vaxxinova and Biobank has been supported by Corfo to establish a
marine biotech innovation center in Puerto Varas in Chile. The new
center, named "Blue Genomics Chile" has a total budget of 17 million
USD. The objective is to make use of new knowledge and
technologies developed in the wake of the Salmon Genome Project
to identify genetic markers and mapping mechanisms specifically
related to disease resistance. The development will form the basis
for commercialization of new products and services that contribute
to a sustainable and profitable development of the aquaculture
sector. Priorities for Blue Genomics Chile are rickettsiosis (SRS) and
salmon lice (Caligus) that represents the largest risk factors in the
industry. The new center will also include other areas such as
functional genomics and genomic related services such as
We are very pleased with this investment in “Blue Genomics
Chile” and it is an important contribution to the fish farming
industry in Chile, not least because it will introduce even more
cutting edge technology to the industry in Chile. I am impressed with
the research conducted in this field here in Norway, and with Aqua
Gen, which I had the pleasure of visiting, says the Chilean
ambassador to Norway, Juan Aníbal Barría.
We also believe the Blue Genomics Chile consortium provides a
very good opportunity for an even closer cooperation between the
Chilean industry and the Norwegian fish farming industry and
Norwegian capital, he says.
There is an increased interest for investing in Chile, and Norway
is moving up on the rankings of foreign investment in Chile.
Norway`s importance is growing in comparison to other countries,
says Ambassador Barría.
Carl Seip Hanevold, Chair of MareLife, geneticist by graduation
and heavily involved in the Norwegian and international industrial
aquaculture revolution over 4 decades, states:
- The described new aqua genomics efforts between Norway and
Chile with AquaGen and allies in pivotal roles, represent a paradigm
shift in genetic enhancement of farmed fish.
Ambassador Juan Aníbal
Barría, Embassy of Chile in
Nina Santi, Head of
Research at AquaGen.
Researchers both in Norway and internationally works to enhance the knowledge regarding the salmon genome.
THE MARELIFE NEWS • NOVEMBER • 20128
MareLife, the independent science-
based marine innovation network, has
reinforced its staff and put in
operation R&D projects initiated by
experienced working groups covering
key areas in marine innovation.
A strong and committed staff combined
with highly experienced people in our
Board and core working groups, provides
Marelife with a solid foundation for moving forward, says Marelife
executive manager Øystein Lie.
He also extends his acknowledgements to the resigning Board
members and Chair who helped developing the current MareLife
platform and he welcomes onboard the new ones.
The staff now consists of Øystein Lie (Executive Manager), Carl
Seip Hanevold (Cermaq) (Working Chairperson), Jon Aulie (The
Norwegian Seafood Federation, Marine Ingredients), Paul J.
Midtlyng (Aquamedic AS, Aquaculture disease control),Sytse
Ybema (Sustainovate, Ocean Resources) and Erik Fedde Lopez,
Fedde Consulting (Administrative matters)
Our five working groups.
Marelife has five working groups in the core areas fisheries,
aquaculture, ingredients industry, commercialization and
reputation. These working groups have been initiating our R&D
projects and strategic efforts like the Havlandet Norge report and
are chaired by the following people:
Fisheries: Lars Olav Lie (Liegruppen AS),
Aquaculture: Petter Arnesen (Marine Harvest ASA
Ingredients Industry: Jon Aulie (MARING Forum, the Norwegian
Seafood Federation, FHL)
Commercialization: Knut Traaseth (Norwegian Venture capital
Reputation building: Geir Myrold (TraceTracker AS)
Board of directors
* Carl Seip Hanevold (Cermaq), Chairperon
* Live Haukvik Aker (Considium Consulting), deputy chairperon
* Kjetil Jakobsen, University of Oslo
* Odd Magne Rødseth, AquaGen
* Dag Knappskog, MSD Animal Health
* Ørjan Olsvik, University of Tromsø
* Torstein Steine, Norwegian University of Life Sciences, UMB
* Espen Rimstad, Norwegian School of Veterinary Science, NVH
* Kristine Naterstad, Nofima
* Jon Aulie, The Norwegian Seafood Federation (FHL) MARING
The Nomination Committee
Sissel Rogne, CEO, The Norwegian Biotechnology Advisory
Board (Committee chairperson)
Director General Arne Benjaminsen, Ministry of fisheries and
coastal affairs (FKD)
Geir Andreassen, CEO, The Norwegian Seafood Federation (FHL)
Marelife has grown its membership base from 17 founding
members to currently 48 members and has a strong international
network. See the member list here:
Carl Seip Hanevold